| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.64B | 18.51B | 24.20B | 23.20B | 29.72B | 23.17B |
| Gross Profit | 9.60B | 9.82B | 9.65B | 9.82B | 11.64B | 9.38B |
| EBITDA | 9.58B | 9.28B | 8.38B | 10.12B | 10.93B | 8.50B |
| Net Income | 3.41B | 3.14B | 3.12B | 4.76B | 4.70B | 4.51B |
Balance Sheet | ||||||
| Total Assets | 97.10B | 135.60B | 139.97B | 133.51B | 130.03B | 89.60B |
| Cash, Cash Equivalents and Short-Term Investments | 12.04B | 12.15B | 12.59B | 8.94B | 10.06B | 10.48B |
| Total Debt | 21.93B | 24.66B | 43.03B | 41.38B | 29.77B | 11.73B |
| Total Liabilities | 41.25B | 78.92B | 81.94B | 75.01B | 68.13B | 33.64B |
| Stockholders Equity | 42.18B | 41.66B | 41.80B | 43.33B | 46.21B | 44.23B |
Cash Flow | ||||||
| Free Cash Flow | 7.88B | 10.10B | 9.93B | -5.58B | -9.34B | -640.92M |
| Operating Cash Flow | 8.79B | 11.09B | 10.71B | -2.68B | -5.37B | 2.25B |
| Investing Cash Flow | -2.68B | -4.17B | -2.50B | -5.79B | -5.85B | -2.23B |
| Financing Cash Flow | -5.07B | -4.68B | -5.30B | 7.97B | 10.21B | -1.46B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $11.32B | 17.43 | 9.18% | 3.48% | 21.35% | 20.96% | |
70 Outperform | $6.04B | 3.99 | 8.14% | 5.03% | -37.50% | 13.93% | |
67 Neutral | $943.14M | 26.96 | 9.08% | 2.67% | 6.24% | 3.35% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
64 Neutral | $26.50B | 22.91 | 10.34% | 2.51% | 12.29% | 13.13% | |
59 Neutral | $2.88B | 21.42 | 13.10% | 2.64% | 10.28% | 13.56% | |
58 Neutral | $2.65B | 20.13 | 7.68% | 2.88% | -2.60% | -33.78% |